Valsartan/Levamlodipine Maleate
- Generic Name
- Valsartan/Levamlodipine Maleate
A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients
Phase 3
Not yet recruiting
- Conditions
- Mild-to-moderate Essential Hypertension
- Interventions
- Drug: Levamlodipine placeboDrug: SYH9056 placebo
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Target Recruit Count
- 606
- Registration Number
- NCT06771245
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath